|
CALGARY, ALBERTA--(Marketwired - June 17, 2016) - Anchor Capital Corporation ("Anchor" or the "Corporation") (TSX VENTURE:ANC.P) is pleased to announce details concerning its proposed qualifying transaction involving a proposed business combination with Intraline Medical Aesthetics PTY Limited ("Intraline"). Intraline is a private global aesthetic pharmaceutical company, whose key products consist of minimally invasive and non-invasive preventative and restorative medical aesthetic and cosmetic products, such as injectable hyaluronic acid dermal fillers, topical products and soon to be added implantable polydioxanone thread products. |
